Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Health Care Edges Higher Amid Cyclical Bias -- Health Care Roundup

11/24/2020 | 04:57pm EST

Health-care companies rose, but not by as much as the broad market, after reports that the Trump administration was cooperating with the transition to the Biden administration spurred demand for more cyclical sectors.

Shares of health insurers, who often administer government plans, such as Cigna, were higher.

The European Union struck a deal with biotech Moderna for the supply of up to 160 million doses of its experimental Covid-19 vaccine, the head of the European Commission said.

Closely held opioid-drug maker Purdue Pharma pleaded guilty to three federal felonies related to the marketing and distribution of its powerful painkiller OxyContin, ending the bankrupt company's exposure to U.S. government action but leaving other liabilities to state and local governments looming.

The death rate from Covid-19 is falling in the U.S., according to infectious-disease experts and biostatisticians, a signal of advancements in treatment of the disease

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

11-24-20 1656ET

All news about MODERNA, INC.
01:43pASTRAZENECA : India to start COVID vaccine exports on Wednesday
RE
01:37pASTRAZENECA : India to start COVID vaccine exports on Wednesday
RE
01:25pMODERNA : says possible allergic reactions to COVID-19 vaccine under investigati..
RE
12:46pMODERNA : receives report of COVID-19 vaccine adverse events in San Diego
RE
12:36pMODERNA : Statement on California Department of Public Health (CDPH) Report
PU
11:35aBrussels targets vaccinating at least 70% of EU adults by summer
RE
11:15aMODERNA : EU commission urges member states to speed up vaccination
AQ
09:11aMODERNA : New York governor asks Pfizer to directly sell COVID-19 vaccine doses
RE
07:31aJapan has pre-ordered COVID-19 vaccine doses for more than four times its pop..
AQ
06:38aPhilippines to buy 20 million Moderna vaccine doses as COVID-19 cases rise
RE
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 -566 M - -
Net cash 2020 2 865 M - -
P/E ratio 2020 -108x
Yield 2020 -
Capitalization 51 304 M 51 304 M -
EV / Sales 2020 94,7x
EV / Sales 2021 4,51x
Nbr of Employees 1 100
Free-Float 90,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 136,60 $
Last Close Price 129,65 $
Spread / Highest target 42,7%
Spread / Average Target 5,36%
Spread / Lowest Target -46,8%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.24.10%51 304
LONZA GROUP AG2.46%48 618
CELLTRION, INC.-12.95%38 786
IQVIA HOLDINGS INC.4.81%36 004
SEAGEN INC.6.06%33 601
HANGZHOU TIGERMED CONSULTING CO.,LTD-1.58%21 572